Transplant Genomics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $71.5M

Transplant Genomics General Information

Description

Provider of molecular diagnostic tests intended for kidney and liver graft dysfunction. The company offers robust molecular signatures indicative of individual patient graft status, prognosis, or response to specific immunosuppressant regimens to complement histological analysis and resolve ambiguous or borderline results, thereby enabling doctors to improve organ transplant outcomes with noninvasive serial monitoring guided by genomics.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 18000 West 99th Street
  • Lenexa, KS 66219
  • United States
+1 (844)
Primary Industry
Laboratory Services (Healthcare)
Parent Company
Vertical(s)
Corporate Office
  • 18000 West 99th Street
  • Lenexa, KS 66219
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transplant Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 25-Jun-2019 $71.5M Completed Generating Revenue
4. Later Stage VC (Series C) 06-Sep-2018 Completed Generating Revenue
3. Grant Completed Startup
2. Early Stage VC (Series B) 03-Apr-2017 $8.05M $15.3M Completed Startup
1. Early Stage VC (Series A) 28-May-2015 $7.29M $7.29M Completed Startup
To view Transplant Genomics’s complete valuation and funding history, request access »

Transplant Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 764,924 $0.001000 8% $9.9 $9.9 1x $9.9 14.99%
To view Transplant Genomics’s complete cap table history, request access »

Transplant Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of molecular diagnostic tests intended for kidney and liver graft dysfunction. The company offers robust molecu
Laboratory Services (Healthcare)
Lenexa, KS
11 As of 2018

Cleveland, OH
 

Lenexa, KS
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Transplant Genomics Competitors (3)

One of Transplant Genomics’s 3 competitors is Cleveland HeartLab, a Formerly VC-backed company based in Cleveland, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cleveland HeartLab Formerly VC-backed Cleveland, OH
Clinical Reference Laboratory Corporation Lenexa, KS
Boston Heart Diagnostics Formerly VC-backed Framingham, MA
You’re viewing 3 of 3 competitors. Get the full list »

Transplant Genomics Patents

Transplant Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023343083-A1 Methods, systems, and compositions for diagnosing pancreatic transplant rejection Pending 12-Sep-2022
EP-4587593-A1 Methods, systems, and compositions for diagnosing pancreatic transplant rejection Pending 12-Sep-2022
US-20250327126-A1 Methods, systems, and compositions for diagnosing pancreatic transplant rejection Pending 12-Sep-2022
WO-2024059514-A1 Methods, systems, and compositions for diagnosing pancreatic transplant rejection Inactive 12-Sep-2022
CA-3228583-A1 Methods of using donor-derived cell-free dna to distinguish acute rejection and other conditions in liver transplant recipients Pending 16-Sep-2021 C12Q1/6883
To view Transplant Genomics’s complete patent history, request access »

Transplant Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transplant Genomics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Founders Capital Partners Angel Group Minority
National Heart, Lung, and Blood Institute Government Minority
Rose Ventures Venture Capital Minority
To view Transplant Genomics’s complete investors history, request access »

Transplant Genomics FAQs

  • When was Transplant Genomics founded?

    Transplant Genomics was founded in 2013.

  • Where is Transplant Genomics headquartered?

    Transplant Genomics is headquartered in Lenexa, KS.

  • What is the size of Transplant Genomics?

    Transplant Genomics has 11 total employees.

  • What industry is Transplant Genomics in?

    Transplant Genomics’s primary industry is Laboratory Services (Healthcare).

  • Is Transplant Genomics a private or public company?

    Transplant Genomics is a Private company.

  • What is the current valuation of Transplant Genomics?

    The current valuation of Transplant Genomics is .

  • What is Transplant Genomics’s current revenue?

    The current revenue for Transplant Genomics is .

  • How much funding has Transplant Genomics raised over time?

    Transplant Genomics has raised $23.3M.

  • Who are Transplant Genomics’s investors?

    Founders Capital Partners, National Heart, Lung, and Blood Institute, and Rose Ventures have invested in Transplant Genomics.

  • Who are Transplant Genomics’s competitors?

    Cleveland HeartLab, Clinical Reference Laboratory, and Boston Heart Diagnostics are competitors of Transplant Genomics.

  • When was Transplant Genomics acquired?

    Transplant Genomics was acquired on 25-Jun-2019.

  • Who acquired Transplant Genomics?

    Transplant Genomics was acquired by Eurofins Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process